Graf Akcie SRPT (Sarepta Therapeutics Inc). Diskuze k akciím SRPT. Aktuální informace SRPT.

Základní informace o společnosti Sarepta Therapeutics Inc (Akcie SRPT)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 6.64B
Hodnota podniku (EV) 6.36B
Tržby 600.082M
EBITDA -616.54
Zisk -634.47
Růst v tržbách Q/Q 19.46 %
Růst v tržbách Y/Y 33.29 %
P/E (Cena vůči ziskům) N/A
Forward P/E 1.22
EV/Sales 10.60
EV/EBITDA N/A
EV/EBIT N/A
PEG 77.40
Price/Sales 11.06
P/FCF N/A
Price/Book 8.71
Účetní hodnota na akcii 9.80
Hotovost na akcii 24.95
FCF vůči ceně -11.80 %
Počet zaměstnanců 866
Tržba na zaměstnance 692.935k
Profit margin -102.60 %
Operating margin -104.52 %
Gross margin 88.26 %
EBIT margin -105.66 %
EBITDA margin -102.74 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -47.15 %
EPS - Očekávaný růst příští rok -21.60 %
Return on assets -22.48 %
Return on equity -94.90 %
ROIC -23.01 %
ROCE -27.16 %
Dluhy/Equity 2.92
Čistý dluh/EBITDA 4.98
Current ratio 5.33
Quick Ratio 4.70
Volatilita 5.43
Beta 0.49
RSI 46.21
Cílová cena analytiků 189
Známka akcie (dle analytiků) 1.39
Insider ownership 4.85 %
Institutional ownership 92.33 %
Počet akcií 79.845M
Procento shortovaných akcií 9.79 %
Short ratio 4.56 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2004
Země United States

Finanční výsledky akcie SRPT

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$380.833$301.034$154.584$5.421$1.253$9.757
Cost Of Goods Sold$56.586$34.193$7.353$0.101--
Gross Profit$324.247$266.841$147.231$5.32$1.253$9.757
Research And Development Expenses$560.909$401.843$166.707$188.272$146.394$94.231
SG&A Expenses$284.812$207.761$122.682$83.749$75.043$49.315
Other Operating Income Or Expenses$-10-$-28.427---
Operating Expenses$1,086.396$644.662$326.222$272.151$221.437$143.546
Operating Income$-705.563$-343.628$-171.638$-266.73$-220.184$-133.789
Total Non-Operating Income/Expense$-8.317$-18.982$123.01$-0.535$0.154$-2
Pre-Tax Income$-713.88$-362.61$-48.628$-267.265$-220.03$-135.789
Income Taxes$1.195$-0.692$2.06---
Income After Taxes$-715.075$-361.918$-50.688$-267.265$-220.03$-135.789
Other Income------
Income From Continuous Operations$-715.075$-361.918$-50.688$-267.265$-220.03$-135.789
Income From Discontinued Operations------
Net Income$-715.075$-361.918$-50.688$-267.265$-220.03$-135.789
EBITDA$-683.461$-339.055$-164.434$-261.039$-214.285$-127.667
EBIT$-705.563$-343.628$-171.638$-266.73$-220.184$-133.789
Basic Shares Outstanding746659494240
Shares Outstanding746659494240
Basic EPS$-9.71$-5.46$-0.86$-5.49$-5.20$-3.39
EPS - Earnings Per Share$-9.71$-5.46$-0.86$-5.49$-5.20$-3.39
# 2020 2019 2018 2017 2016 2015
Current Ratio5.54798.211113.90944.95183.60466.7214
Long-term Debt / Capital0.45460.28950.350.01760.07290.0149
Debt/Equity Ratio0.83340.40740.54620.0480.12290.0256
Gross Margin85.141588.641595.243498.1369100100
Operating Margin-185.2683-114.1492-111.0322-4920.31-17572.54-1371.21
EBIT Margin-185.2683-114.1492-111.0322-4920.31-17572.54-1371.21
EBITDA Margin-179.4648-112.6301-106.3719-4815.33-17101.75-1308.466
Pre-Tax Profit Margin-187.4522-120.4548-31.4573-4930.179-17560.26-1391.709
Net Profit Margin-187.766-120.225-32.7899-4930.179-17560.26-1391.709
Asset Turnover0.20890.18330.11820.01280.00460.0331
Inventory Turnover Ratio0.33020.27260.08790.0079--
Receiveable Turnover4.19066.1385.24581.03690.31514.0385
Days Sales In Receivables87.100759.465269.5791352.00521158.50490.3802
ROE - Return On Equity-87.3975-35.0602-6.4226-79.3799-115.5941-54.8304
Return On Tangible Equity-88.7531-35.4578-6.5416-81.3307-119.7735-56.1664
ROA - Return On Assets-39.229-22.0403-3.8753-63.0188-80.3669-46.025
ROI - Return On Investment-47.6689-24.9112-4.175-77.9805-107.1665-54.0151
Book Value Per Share10.882314.524412.18086.14864.17155.9947
Operating Cash Flow Per Share-0.3341-1.92231.1037-1.5137-0.3229-1.3002
Free Cash Flow Per Share-0.221-2.64141.0093-1.54290.2324-1.8659

Porovnání s konkurencí: Akcie SRPT

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
SRPT N/A 77.40 33.29 % -21.60 % -94.90 % 8.71 -102.60 %
Akcie ALNY N/A N/A 99.18 % -27.98 % -88.43 % 23.92 -174.15 %
Akcie ALNY N/A N/A 99.18 % -27.98 % -88.43 % 23.92 -174.15 %
Akcie BCRX N/A N/A 60.87 % 11.54 % 513.75 % -133.91 -1,026.35 %
Akcie BCRX N/A N/A 60.87 % 11.54 % 513.75 % -133.91 -1,026.35 %
Akcie GILD 16.42 0.56 20.13 % -20.85 % 27.79 % 4.69 0.50 %
Akcie GILD 16.42 0.56 20.13 % -20.85 % 27.79 % 4.69 0.50 %
Akcie INSM N/A N/A 4.08 % 33.33 % -109.79 % 12.17 -178.87 %
Akcie INSM N/A N/A 4.08 % 33.33 % -109.79 % 12.17 -178.87 %
Akcie NVAX N/A N/A 2,252.66 % 21.81 % -150.88 % 19.13 -87.94 %
Akcie NVAX N/A N/A 2,252.66 % 21.81 % -150.88 % 19.13 -87.94 %
Akcie PTCT N/A 0.92 51.55 % 38.83 % -105.54 % 5.44 -115.07 %
Akcie PTCT N/A 0.92 51.55 % 38.83 % -105.54 % 5.44 -115.07 %
Akcie RTRX N/A N/A 12.53 % -35.71 % -29.27 % 0.02 N/A %
Akcie RTRX N/A N/A 12.53 % -35.71 % -29.27 % 0.02 N/A %
Akcie RTRX N/A N/A 12.53 % -35.71 % -29.27 % 0.02 N/A %
Akcie RTRX N/A N/A 12.53 % -35.71 % -29.27 % 0.02 N/A %

Nedávné obchody insiderů: Akcie SRPT

Jméno Obchod Cena Objem
Hans Lennart Rudolf Wigzell
Director
Option
4 Mar 2020
$8.46 $42,300
Sandesh Mahatme
EVP, CFO, and CBO
Option
11 May 2020
$19.69 $74,940
Richard Barry
Director
Prodej
15 May 2020
$141.26 $4,237,800
Hans Lennart Rudolf Wigzell
Director
Option
20 May 2020
$10.08 $50,400
David T Howton
EVP and General Counsel
Option
22 Jun 2020
$25.76 $2,707,943
Joseph Bratica
Principal Financial Officer
Option
3 Aug 2020
$29.60 $33,300
Richard Barry
Director
Prodej
7 Aug 2020
$158.50 $4,755,000
Hans Lennart Rudolf Wigzell
Director
Option
10 Aug 2020
$34.92 $349,200
Joseph Bratica
Principal Financial Officer
Option
8 Dec 2020
$29.60 $33,300
Mary Ann Gray
Director
Option
10 Dec 2020
$160.00 $154,720
Joseph Bratica
Principal Financial Officer
Option
11 Dec 2020
$71.45 $79,667

Diskuze k akciím SRPT